GIP/GLP-1/Glucagon mono/dual/triple therapeutic (Zealand Pharma)

N/A

Report date: 2025/03/20 16:12:00

Base Information

Drug NameGIP/GLP-1/Glucagon mono/dual/triple therapeutic (Zealand Pharma)
Drug Alias Nameglucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor/glucagon mono/dual/triple therapeutic (Zealand Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor modulatorsGlucagon-like peptide 1 receptor modulators
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesZealand Pharma A/S
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A